Signet Financial Management LLC Boosts Holdings in Eli Lilly And Co (LLY)

Share on StockTwits

Signet Financial Management LLC grew its holdings in shares of Eli Lilly And Co (NYSE:LLY) by 2.3% during the 4th quarter, HoldingsChannel reports. The fund owned 48,609 shares of the company’s stock after acquiring an additional 1,088 shares during the quarter. Eli Lilly And Co makes up 1.2% of Signet Financial Management LLC’s investment portfolio, making the stock its 18th biggest position. Signet Financial Management LLC’s holdings in Eli Lilly And Co were worth $5,625,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the business. Oregon Public Employees Retirement Fund grew its holdings in shares of Eli Lilly And Co by 17,720.8% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 42,420,406 shares of the company’s stock worth $367,000 after purchasing an additional 42,182,367 shares during the last quarter. FMR LLC grew its holdings in shares of Eli Lilly And Co by 526.5% in the third quarter. FMR LLC now owns 7,444,216 shares of the company’s stock worth $798,838,000 after purchasing an additional 6,255,915 shares during the last quarter. BlackRock Inc. grew its holdings in shares of Eli Lilly And Co by 3.0% in the fourth quarter. BlackRock Inc. now owns 68,956,519 shares of the company’s stock worth $7,979,649,000 after purchasing an additional 2,030,845 shares during the last quarter. TIAA CREF Investment Management LLC grew its holdings in shares of Eli Lilly And Co by 54.0% in the third quarter. TIAA CREF Investment Management LLC now owns 4,693,492 shares of the company’s stock worth $503,659,000 after purchasing an additional 1,644,879 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Eli Lilly And Co by 59.7% in the fourth quarter. Jennison Associates LLC now owns 3,425,424 shares of the company’s stock worth $396,390,000 after purchasing an additional 1,280,878 shares during the last quarter. 78.69% of the stock is currently owned by hedge funds and other institutional investors.

NYSE:LLY opened at $128.31 on Friday. The firm has a market capitalization of $132.70 billion, a P/E ratio of 23.12, a P/E/G ratio of 2.58 and a beta of 0.33. Eli Lilly And Co has a twelve month low of $74.51 and a twelve month high of $130.75. The company has a current ratio of 1.73, a quick ratio of 1.38 and a debt-to-equity ratio of 1.07.

Eli Lilly And Co (NYSE:LLY) last released its quarterly earnings results on Wednesday, February 6th. The company reported $1.33 earnings per share for the quarter, missing the consensus estimate of $1.36 by ($0.03). The company had revenue of $6.44 billion during the quarter, compared to the consensus estimate of $6.28 billion. Eli Lilly And Co had a net margin of 13.16% and a return on equity of 44.66%. The business’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.14 EPS. As a group, analysts predict that Eli Lilly And Co will post 5.64 earnings per share for the current fiscal year.

Several research analysts have recently issued reports on LLY shares. Citigroup cut shares of Eli Lilly And Co from a “buy” rating to a “neutral” rating and set a $115.00 target price on the stock. in a report on Monday, November 26th. Zacks Investment Research upgraded shares of Eli Lilly And Co from a “hold” rating to a “buy” rating and set a $128.00 target price on the stock in a report on Wednesday, November 28th. BMO Capital Markets restated a “buy” rating on shares of Eli Lilly And Co in a report on Wednesday, December 19th. Morgan Stanley set a $116.00 target price on shares of Eli Lilly And Co and gave the stock a “hold” rating in a report on Thursday, December 20th. Finally, Argus restated a “buy” rating on shares of Eli Lilly And Co in a report on Thursday, December 27th. Ten analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $111.56.

In related news, SVP Stephen F. Fry sold 14,847 shares of Eli Lilly And Co stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $123.16, for a total value of $1,828,556.52. Following the sale, the senior vice president now owns 109,663 shares in the company, valued at $13,506,095.08. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Donald A. Zakrowski sold 1,000 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $127.01, for a total value of $127,010.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 833,190 shares of company stock worth $102,388,102. 0.11% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This story was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4240742/signet-financial-management-llc-boosts-holdings-in-eli-lilly-and-co-lly.html.

Eli Lilly And Co Company Profile

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.

See Also: How to Invest in Marijuana Stocks

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly And Co (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly And Co (NYSE:LLY)

Receive News & Ratings for Eli Lilly And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly And Co and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Hino Motors  & Morgan Advanced Materials  Head-To-Head Survey
Hino Motors & Morgan Advanced Materials Head-To-Head Survey
Lindbrook Capital LLC Has $2.50 Million Position in iShares Russell 2000 ETF
Lindbrook Capital LLC Has $2.50 Million Position in iShares Russell 2000 ETF
Endorsit  Market Capitalization Achieves $0.00
Endorsit Market Capitalization Achieves $0.00
Italian Lira  24 Hour Volume Tops $3,095.00
Italian Lira 24 Hour Volume Tops $3,095.00
Brokers Set Expectations for Anthem Inc’s Q3 2019 Earnings
Brokers Set Expectations for Anthem Inc’s Q3 2019 Earnings
Grand Canyon Education  Cut to “Hold” at Zacks Investment Research
Grand Canyon Education Cut to “Hold” at Zacks Investment Research


© 2006-2019 Ticker Report